This is a competing renewal of a postdoctoral training program entitled """"""""Training in Investigative Infectious Diseases"""""""". The program is based in the Section of Infectious Diseases within the Department of Medicine at the Yale University School of Medicine. The program's overall goal is to produce exceptional physician-scientists and investigators who use modern laboratory research methods to study human infectious diseases. We expect to develop the next generation of infectious disease faculty at major universities that have the training and knowledge to span the gap between basic biology and issues in clinical infectious diseases. The program is designed primarily for M.D.'s and M.D./Ph.D.'s who have completed their subspecialty clinical training in the Infectious Diseases fellowship program at Yale, but selected M.D.s or M.D./Ph.D.s with clinical training in other fields will also be eligible to participate. The training faculty consists of 20 laboratory-based, and 9 translational researchers from 2 clinical (Medicine and Pediatrics) and 3 basic sciences departments (Microbial Pathogenesis, Immunobiology, and Microbial Diseases within the Department of Epidemiology and Public Health). The 3 major areas of research are (1) Innate Immunity and Microbes, (2) Vector-borne Diseases and (3) Molecular and Human Infectious Disease Pathogenesis. A primary mentor and co-mentor will supervise each trainee, and a training committee will monitor their progress. The trainees will have access to the newest programs and facilities at Yale, including working in the Anlyan Center for Medical Research and Education, The Boyer Center for Molecular Medicine, and/or participating in the Investigative Medicine Ph.D. program or Robert Wood Johnson Clinical Scholars program -- two novel programs designed specifically for M.D.s who have completed their clinical training. We are highly confident that this training program will provide its trainees with outstanding opportunities to pursue careers in investigative infectious diseases and bring a greater understanding of basic biological principles to current problems in medicine. This program will help train the next generation of infectious disease investigators at academic medical centers, with a focus on applying basic research to clinical medicine.

Public Health Relevance

The understanding and treatment of infectious diseases requires a cadre of highly trained physician scientists. The goals of this program are to train and develop the next generation of infectious disease investigators, by seeking highly qualified trainees, and gearing access to other highly qualified trainees and outstanding mentors, with a wide range of backgrounds. This approach has been highly successful in producing investigators devoted to dissecting the mechanisms of infectious diseases, and towards developing new prevention and therapeutic strategies for infectious diseases and national importance. This broad type of study and training is becoming even more critical as medical centers expand and evolve in the global community. It is anticipated that it will remain so with the training plan and mentorship that is provided by this program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007517-12
Application #
8305460
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
1997-07-01
Project End
2016-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
12
Fiscal Year
2012
Total Cost
$265,866
Indirect Cost
$19,338
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Datta, Rupak; Advani, Sonali; Rink, Andrea et al. (2018) Frequency of Infection during Fever Episodes among Long-Term Care Residents. J Gerontol Geriatr Res 7:
Datta, Rupak; McManus, Dayna; Topal, Jeffrey et al. (2018) Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases. Open Forum Infect Dis 5:ofx277
van Duin, David (2017) Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know. Virulence 8:379-382
Lindquist, Lee A; Miller, Rachel K; Saltsman, Wayne S et al. (2017) SGIM-AMDA-AGS Consensus Best Practice Recommendations for Transitioning Patients' Healthcare from Skilled Nursing Facilities to the Community. J Gen Intern Med 32:199-203
Muthulingam, Dharushana (2017) Health Insurance and the Promise of Incrementalism. J Womens Health (Larchmt) 26:1263-1264
Gonzalo-Gil, Elena; Ikediobi, Uchenna; Sutton, Richard E (2017) Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers. Yale J Biol Med 90:245-259
Nance, Robin M; Delaney, J A Chris; Golin, Carol E et al. (2017) Co-calibration of two self-reported measures of adherence to antiretroviral therapy. AIDS Care 29:464-468
Nathavitharana, Ruvandhi R; Cudahy, Patrick G T; Schumacher, Samuel G et al. (2017) Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J 49:
Kanamori, Hajime; Parobek, Christian M; Juliano, Jonathan J et al. (2017) A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center. Antimicrob Agents Chemother 61:
Strassle, Paula D; Williams, Felicia N; Napravnik, Sonia et al. (2017) Improved Survival of Patients With Extensive Burns: Trends in Patient Characteristics and Mortality Among Burn Patients in a Tertiary Care Burn Facility, 2004-2013. J Burn Care Res 38:187-193

Showing the most recent 10 out of 65 publications